In the U.S., Onivyde often runs near $65 per mg (Medicare ASP, Q3-2025), so one infusion can land around $3,000–$5,000 before site fees.
Price questions around oncology drugs rarely have a single tidy number. With this treatment, the bill you see reflects the drug itself, the dose your care team prescribes, and what the infusion center charges for pharmacy handling, nursing time, and overhead. Insurance design and any assistance you qualify for then shape the final out-of-pocket figure. Below, you’ll see how the per-mg benchmark translates into real-world totals, how many vials are used at common doses, and what levers can reduce your spend.
What Drives The Price You’ll See
Three pieces stack into the total:
- Drug units billed: The chemotherapy is billed per milligram under a specific HCPCS code. Your dose depends on body surface area (m2) and the regimen your oncologist selects.
- Payment benchmark: Many U.S. payers peg payment to Medicare’s “average sales price” (ASP) plus a small add-on. Commercial contracts may differ but often track the same direction.
- Facility and professional fees: Expect line items for pharmacy compounding, IV chair time, nursing, premeds, and labs. These can rival the drug line in some settings.
How The Numbers Fit Together (Early Snapshot)
The table below gives an at-a-glance view of the main cost components you’ll encounter with this liposomal irinotecan product. It keeps things concrete without burying you in codes.
| Item | Typical Detail | Why It Matters |
|---|---|---|
| Billing Unit | 1 mg via HCPCS J9205 | All charges scale with milligrams billed for the infusion. |
| Vial Strength | 43 mg in a 10 mL single-use vial | Determines how many vials are needed to reach your dose. |
| Benchmark Price | About $65 per mg (Medicare ASP + add-on, Q3-2025) | Many plans reference this benchmark when paying facilities. |
| Common Dose | 70 mg/m2 every 2 weeks | Body size (BSA) sets your milligram target every cycle. |
| Facility Charges | Pharmacy, chair time, nursing, premeds, labs | These are separate from the drug itself and vary by site. |
| Patient Assistance | Copay support for eligible commercial plans; PAP for select cases | Can drop out-of-pocket dramatically if you qualify. |
How Much Does Onivyde Cost Per Mg — 2025 Update
Medicare’s public file lists payment limits each quarter. For July–September 2025, the allowance for the liposomal irinotecan code works out near the mid-$60s per mg. Commercial contracts may pay a bit more or less, but this benchmark is a practical yardstick for estimates.
If a center buys the drug at a negotiated acquisition cost lower than the benchmark, it keeps the spread to fund pharmacy operations. If its cost is higher, it may seek separate adjustments or rely on better purchasing terms. That’s why lists on consumer price sites can differ from what you see in a hospital bill.
Turning Per-Mg Into Per-Visit Numbers
Your dose comes from body surface area (BSA). Using 70 mg/m2 as the standard regimen, here’s how the math plays out at common BSAs:
- BSA 1.6 m2: 112 mg target → drug line near $7,300 at an ASP-based benchmark, before site fees.
- BSA 1.8 m2: 126 mg target → drug line near $8,200 at that same benchmark, before site fees.
- BSA 2.0 m2: 140 mg target → drug line near $9,100 at that same benchmark, before site fees.
Those figures reflect the billed drug only. Facilities then add charges for preparation, infusion, and supportive meds. In academic centers or large hospital outpatient departments, the fully loaded visit can exceed the drug line; in office-based oncology, the non-drug portion may be leaner.
How Many Vials Does A Typical Dose Use?
Each single-use vial contains 43 mg. Pharmacies round to the nearest full milligram and must discard any remainder from a pierced vial. That means even a dose of 86 mg uses two vials, while a 140 mg dose uses four. Here’s a quick feel for common doses:
- ~90 mg dose → 3 vials (129 mg drawn, remainder discarded)
- ~112 mg dose → 3 vials (129 mg drawn, remainder discarded)
- ~140 mg dose → 4 vials (172 mg drawn, remainder discarded)
Because of single-use rules, wastage is normal and priced into claims. Some payers track and reimburse that wastage when modifiers are used correctly.
What Retail Price Sites Say
Public drug price directories list a per-vial cash range. You’ll often see a 10 mL vial listed between roughly $1,900 and the low-$3,000s depending on the source and update date. Those listings help with ballpark comparisons but may not match your infusion claim, which is built from per-mg billing plus the facility’s own rate sheet and payer contract.
Sample Cost Scenarios (Using ASP Benchmark)
These examples use the quarter’s per-mg allowance to paint a realistic window for the drug line on the claim. They don’t include site fees, professional services, or other drugs given the same day.
| BSA & Dose | Mg Billed (70 mg/m2) | Drug Line (ASP-Based) |
|---|---|---|
| 1.5 m2 → 105 mg | 105 mg | About $6,800–$7,000 |
| 1.7 m2 → 119 mg | 119 mg | About $7,600–$7,900 |
| 1.9 m2 → 133 mg | 133 mg | About $8,600–$8,800 |
| 2.1 m2 → 147 mg | 147 mg | About $9,500–$9,700 |
Why Two Patients Can Pay Different Amounts
Body size differs. A taller or heavier person with a larger BSA receives more milligrams and more vials.
Site of care differs. Hospital outpatient departments tend to have higher facility fees than independent infusion centers.
Insurance benefit design differs. Coinsurance percentages, annual caps, and whether your plan treats the drug as a medical or pharmacy benefit all change the math.
Assistance programs differ. Commercial patients who qualify for copay support may see a small bill. Uninsured patients who meet strict income and clinical criteria may access a manufacturer assistance pathway for the drug itself, while still owing non-drug visit charges.
What To Ask Your Care Team
- “What dose in milligrams will I receive on day 1?” Knowing the exact mg lets you estimate the drug line on the claim with real numbers.
- “How many vials does your pharmacy plan to open?” This hints at wastage and whether a different day’s scheduling could reduce it.
- “What are the infusion and facility fees separate from the drug?” Ask for a one-page estimate of non-drug charges.
- “Do you use the Medicare ASP benchmark for contracting?” If yes, you can multiply your mg dose by that quarter’s allowance to project the drug portion.
- “Can you check copay support or a patient assistance program for me?” Staff can help enroll you if you qualify.
Dose Basics That Influence Cost
Standard dosing lands at 70 mg per m2 every two weeks with fluorouracil and leucovorin. People with certain UGT1A1 genetic variants may start lower. Dose reductions for side effects are common, and any change up or down affects how many vials are billed. Your oncologist sets the dose based on benefit and tolerability, not price, but teams can time cycles and group orders to limit waste where safe.
Two Authoritative Links You Can Use
To see the current quarterly allowance many payers reference, check the CMS ASP Pricing Files. For vial strength and handling, the current FDA label lists the 43 mg/10 mL single-dose presentation. If you’re insured commercially, your navigator can also review manufacturer copay assistance to see whether you qualify.
How To Build A Personalized Estimate
- Grab your BSA. It’s usually in your chart; if not, your nurse can provide it.
- Calculate the mg dose. Multiply BSA by 70 mg. Round to the nearest whole mg.
- Convert to vials. Divide by 43 mg, then round up to a whole vial count.
- Apply a per-mg benchmark. Use the latest quarter’s allowance from the CMS file as a working figure, or ask your center which benchmark they use.
- Add non-drug charges. Ask your center’s financial counselor for the pharmacy/infusion estimate tied to your insurance.
- Layer in assistance. If eligible, apply copay support or a patient assistance approval to see the out-of-pocket number.
Ways To Reduce What You Pay
- Check copay help early. Commercial plans often allow manufacturer copay programs. Enrollment can be fast once benefits are verified.
- Ask about site-of-care options. Some plans steer to lower-cost infusion settings. Switching locations can cut non-drug charges.
- Coordinate scheduling. If your dose sits just over a vial breakpoint, your team may time cycles or dose-adjust within the clinical plan to avoid an extra vial. Any change must be medically appropriate.
- Appeal denials quickly. If a claim is rejected or underpaid, request a peer-to-peer or formal appeal. Financial counselors do this every day.
What A Full Cycle Can Cost
Across U.S. centers, a two-week cycle that includes this drug alongside partner agents often totals five figures on the claim when you combine drug and facility lines. After insurance processing, coinsurance applies to the allowed amount. With copay support, many commercially insured patients see a small bill for the drug portion; Medicare patients can look to supplemental coverage and foundation grants where available.
Key Takeaways
- The bill scales with milligrams billed under J9205 and the quarter’s benchmark allowance.
- Each vial contains 43 mg, which drives how many vials the pharmacy must open for your dose.
- Non-drug facility charges can rival the drug line and vary by site.
- Assistance options and benefit design can drop the out-of-pocket meaningfully.
Plain-English Answers To Common Money Questions
“Why does a friend at another hospital pay a different amount?” Different contracts, different facility fees, and different BSAs create different totals.
“Can I know the number before my visit?” Yes. Ask for an estimate sheet that lists the mg dose, vials planned, the benchmark rate used, and the facility’s non-drug fees.
“Does the cash price online apply to me?” Those listings describe vial prices and coupons at retail, which rarely reflect per-mg medical billing in infusion settings.
“Is there help if I’m uninsured?” A manufacturer program may supply the drug at no cost for eligible cases; you may still see non-drug visit charges from the site.
